Chromadex Corp (CDXC)

Finanzdaten der Chromadex Corp-Aktie (CDXC)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.52% 22.15	21.20	19.50	20.32	22.56
Cost Of Revenue	5.30% 8.697	8.259	7.526	7.967	9.038
Gross Profit	4.01% 13.46	12.94	11.97	12.36	13.52
Operating Expenses	8.26% 14.19	13.11	13.12	14.67	15.49
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	7.11% 22.88	21.36	20.64	22.64	24.52
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	335.12% -0.731	-0.168	-1.147	-2.316	-1.968
Net Interest Income/Expense	15.25% 0.239	0.282	0.188	0.125	0.066
Interest Income/Expense After Provision For Losses	15.25% 0.239	0.282	0.188	0.125	0.066
Income/Loss From Continuing Operations Before Tax	4.52% 22.15	21.20	19.50	20.32	22.56
Income/Loss From Continuing Operations After Tax	531.58% -0.492	0.114	-0.959	-2.191	-1.902
Net Income/Loss	531.58% -0.492	0.114	-0.959	-2.191	-1.902
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	159.96K% 75.23	0.047	75.05	74.97	74.80
Diluted Average Shares	159.96K% 75.23	0.047	75.05	74.97	74.80
Basic Earnings Per Share	-0.01	-	-0.01	-0.03	-0.03
Diluted Earnings Per Share	-0.01	-	-0.01	-0.03	-0.03
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-